JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.58B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1B |
| 3 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$958M |
| 4 |
Eli Lilly
LLY
|
+$776M |
| 5 |
AGN
Allergan plc
AGN
|
+$751M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.98B |
| 3 |
Johnson & Johnson
JNJ
|
+$1.31B |
| 4 |
Merck
MRK
|
+$837M |
| 5 |
Bread Financial
BFH
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.59% |
| 2 | Financials | 15.13% |
| 3 | Healthcare | 11.59% |
| 4 | Technology | 11.09% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HT
1851
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $7.76M | ﹤0.01% |
342,337
+4,564
| +1% | +$116K |
2013 Q2
9 quarters
|
|
1852
Nexstar Media Group
NXST
$4.89B
| $7.75M | ﹤0.01% |
163,782
+11,912
| +8% | +$604K |
2013 Q2
9 quarters
|
|
|
ARAV
1853
DELISTED
Aravive, Inc. Common Stock
ARAV
| $7.75M | ﹤0.01% |
112,021
+16,339
| +17% | +$1.53M |
2014 Q2
5 quarters
|
|
|
ACHN
1854
DELISTED
Achillion Pharmaceuticals
ACHN
| $7.75M | ﹤0.01% |
1,121,293
+246
| +0% | +$2K |
2014 Q3
4 quarters
|
|
1855
Grupo Cibest SA
CIB
$21.5B
| $7.74M | ﹤0.01% |
240,271
+51,397
| +27% | +$1.85M |
2013 Q2
9 quarters
|
|
1856
PUT
American International
AIG
$39.4B
| $7.72M | ﹤0.01% |
+135,900
| New | +$8.31M |
2015 Q3
0 quarters
|
|
|
GXP
1857
DELISTED
Great Plains Energy Incorporated
GXP
| $7.72M | ﹤0.01% |
285,644
-66,356
| -19% | -$1.7M |
2013 Q2
9 quarters
|
|
1858
PUT
Elevance Health
ELV
$82.8B
| $7.7M | ﹤0.01% |
55,000
-2,947,860
| -98% | -$443M |
2014 Q2
5 quarters
|
|
|
UIL
1859
DELISTED
UIL HOLDINGS
UIL
| $7.7M | ﹤0.01% |
153,138
+2,372
| +2% | +$112K |
2013 Q2
9 quarters
|
|
1860
Oceaneering
OII
$4.42B
| $7.69M | ﹤0.01% |
195,787
-38,296
| -16% | -$1.59M |
2013 Q2
9 quarters
|
|
1861
iShares Core S&P Small-Cap ETF
IJR
$104B
| $7.68M | ﹤0.01% |
144,240
-36,366
| -20% | -$2.06M |
2013 Q2
9 quarters
|
|
|
EFOR
1862
Everforth Inc
EFOR
$1.48B
| $7.67M | ﹤0.01% |
207,820
+173,985
| +514% | +$6.61M |
2013 Q2
9 quarters
|
|
|
LION
1863
DELISTED
Fidelity Southern Corporation
LION
| $7.67M | ﹤0.01% |
362,599
+6,400
| +2% | +$123K |
2013 Q2
9 quarters
|
|
1864
PUT
Salesforce
CRM
$195B
| $7.64M | ﹤0.01% |
110,000
-28,400
| -21% | -$2.01M |
2014 Q3
4 quarters
|
|
|
CEMP
1865
DELISTED
Cempra, Inc.
CEMP
| $7.62M | ﹤0.01% |
+273,587
| New | +$10.2M |
2015 Q3
0 quarters
|
|
1866
Federal Signal
FSS
$6.85B
| $7.61M | ﹤0.01% |
554,815
+6,435
| +1% | +$91.4K |
2013 Q2
9 quarters
|
|
1867
Ironwood Pharmaceuticals
IRWD
$621M
| $7.6M | ﹤0.01% |
870,912
+248,587
| +40% | +$2.32M |
2014 Q3
4 quarters
|
|
|
PRXL
1868
DELISTED
Parexel International Corp
PRXL
| $7.59M | ﹤0.01% |
122,613
-16,612
| -12% | -$1.12M |
2013 Q2
9 quarters
|
|
1869
CALL
Freeport-McMoran
FCX
$99.5B
| $7.57M | ﹤0.01% |
781,274
-413,168
| -35% | -$4.96M |
2014 Q3
4 quarters
|
|
1870
Comfort Systems
FIX
$59.3B
| $7.56M | ﹤0.01% |
277,431
-1,158,315
| -81% | -$31M |
2013 Q2
9 quarters
|
|
1871
iShares MSCI ACWI ex US ETF
ACWX
$15.9B
| $7.56M | ﹤0.01% |
193,547
-46,792
| -19% | -$1.97M |
2013 Q2
9 quarters
|
|
|
MTGE
1872
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $7.55M | ﹤0.01% |
512,311
+472,911
| +1,200% | +$7.45M |
2013 Q2
9 quarters
|
|
1873
CVB Financial
CVBF
$3.87B
| $7.55M | ﹤0.01% |
452,179
-9,875
| -2% | -$169K |
2013 Q2
9 quarters
|
|
1874
Flowers Foods
FLO
$1.18B
| $7.53M | ﹤0.01% |
304,364
+148,774
| +96% | +$3.38M |
2013 Q2
9 quarters
|
|
1875
PUT
MetLife
MET
$60B
| $7.53M | ﹤0.01% |
179,071
+99,633
| +125% | +$4.65M |
2014 Q3
4 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2015 Portfolio in Review
As of Q3 2015, JP Morgan Chase held 4,367 positions worth $374B, down 12% from $424B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase withdrew a net $18B in Q3 2015, closing 488 positions and reducing 1,582 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, JP Morgan Chase opened a new position in COLUMBIA PIPELINE GROUP IN COM STK (DE) worth $672M.
- JP Morgan Chase's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 36,762,567 shares worth $672M.
- JP Morgan Chase added most to Xtrackers MSCI EAFE Hedged Equity ETF in Q3 2015, an estimated $1.58B increase.
- JP Morgan Chase's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.23B.
- JP Morgan Chase fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $559M.
- JP Morgan Chase's ten largest holdings make up 17% of its $374B portfolio in Q3 2015.
- JP Morgan Chase opened 374 new positions and closed 488 in Q3 2015.
- JP Morgan Chase's portfolio value fell 12% quarter-over-quarter to $374B.
Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.